SCHEMBL2157267

SCHEMBL2157267

O=C(O)c1cccc2ccc3ccccc3c12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A1 P22736 1/20 0.70
NR4A2 P43354 1/20 0.70
NR4A3 Q92570 1/20 0.70
HSD17B10 Q99714 3/20 0.62
CDC25B P30305 1/20 0.61
WDR5 P61964 1/20 0.60
LDHA P00338 1/20 0.58
ALDH1A1 P00352 4/20 0.50
ALOX15 P16050 1/20 0.50
SOS1 Q07889 1/20 0.49
PARP1 P09874 1/20 0.49
MMP3 P08254 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HPGD P15428 2/20 0.47
LMNA P02545 1/20 0.47
CSNK2A2 P19784 1/20 0.47
CSNK2B P67870 1/20 0.47
CSNK2A1 P68400 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12486214 0.91 NR4A1 (0.63) NR4A1NR4A2NR4A3HSD17B10CDC25B
SCHEMBL2834703 0.85 HSD17B10 (0.75) NR4A1NR4A2NR4A3HSD17B10CDC25B
SCHEMBL28522365 0.85 NR4A1 (0.55) NR4A1NR4A2NR4A3HSD17B10CDC25B
SCHEMBL23698265 0.84 NR4A1 (0.53) NR4A1NR4A2NR4A3HSD17B10CDC25B
Salicylic Acid SCHEMBL27756593 0.84 ALDH1A1 (0.60) NR4A1NR4A2NR4A3HSD17B10CDC25B
SCHEMBL6316200 0.83 HSD17B10 (0.56) NR4A1NR4A2NR4A3HSD17B10CDC25B
Ammonia Solution, Strong SCHEMBL31590816 0.83 HSD17B10 (0.72) NR4A1NR4A2NR4A3HSD17B10CDC25B
Phenanthrene SCHEMBL31651179 0.83 NR4A1 (0.75) NR4A1NR4A2NR4A3HSD17B10CDC25B
Naphthoic Acid SCHEMBL17258 0.83 NR4A1 (1.00) NR4A1NR4A2NR4A3HSD17B10CDC25B
Ammonia Solution, Strong SCHEMBL31590375 0.83 HSD17B10 (0.72) NR4A1NR4A2NR4A3HSD17B10CDC25B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115612483-B Regulation and control CsPbBr3Method for prolonging service life of quantum dot excited state 中国科学院大连化学物理研究所 2024-11-15 CN claimed
CN-115612483-A Regulation and control CsPbBr 3 Method for quantum dot excited state lifetime 中国科学院大连化学物理研究所 2023-01-17 CN claimed
US-10478652-B2 Method for biodegrading high molecular weight polycyclic aromatic hydrocarbon pyrenes with halophilic bacteria KING FADH UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-11-19 US claimed
EP-2748244-B1 METAL CARBOXYLATE ADDITIVES FOR THERMOPLASTICS TOTAL PETROCHEMICALS & REFINING USA INC (US) 2017-09-27 EP claimed
CN-103917585-B For the carboxylate metal salt additives of thermoplastic resin FINA TECHNOLOGY, INC. (US) 2015-08-19 CN claimed
US-9045615-B2 Metal carboxylate additives for thermoplastics FINA TECHNOLOGY, INC. (US) 2015-06-02 US claimed
CN-103917585-A Metal carboxylate additives for thermoplastics CRAY VALLEY TECHNOLOGY USA LLC 2014-07-09 CN claimed
EP-2748244-A1 METAL CARBOXYLATE ADDITIVES FOR THERMOPLASTICS Total Petrochemicals & Refining USA, Inc. (US) 2014-07-02 EP claimed
US-20130053496-A1 METAL CARBOXYLATE ADDITIVES FOR THERMOPLASTICS CRAY VALLEY TECHNOLOGY USA, LLC (US) 2013-02-28 US claimed
WO-2013028485-A1 METAL CARBOXYLATE ADDITIVES FOR THERMOPLASTICS CRAY VALLEY TECHNOLOGY USA, LLC (US) 2013-02-28 WO claimed
CN-122079318-A Method and device for repairing pyrene pollution by coupling electrocatalytic oxidation with surfactant 2026-05-26 CN disclosed
CN-115612483-B Regulation and control CsPbBr3Method for prolonging service life of quantum dot excited state 中国科学院大连化学物理研究所 2024-11-15 CN disclosed
CN-115612483-A Regulation and control CsPbBr 3 Method for quantum dot excited state lifetime 中国科学院大连化学物理研究所 2023-01-17 CN disclosed
CN-112708580-A Construction method and application of symbiotic flora for phenanthrene and pyrene combined aerobic degradation 吉林化工学院 2021-04-27 CN disclosed
US-10478652-B2 Method for biodegrading high molecular weight polycyclic aromatic hydrocarbon pyrenes with halophilic bacteria KING FADH UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2019-11-19 US disclosed
WO-2006088272-A1 ENAMEL VANISH COMPOSITION FOR ENAMEL WIRE AND ENAMEL WIRE USING THE SAME LS CABLE LTD. (KR) 2006-08-24 WO disclosed
US-20060106181-A1 Method for producing allyl compound, and ether or ester compound produced thereby MITSUBISHI CHEMICAL CORPORATION (JP) 2006-05-18 US disclosed
US-20050075518-A1 Method for producing allyl compound, and allyl compound produced thereby MITSUBISHI CHEMICAL CORPORATION (JP) 2005-04-07 US disclosed
US-20040147757-A1 Method for producing allyl compound, and ether or ester compound produced thereby MITSUBISHI CHEMICAL CORPORATION (JP) 2004-07-29 US disclosed
US-20040092777-A1 Method for producing allyl compound MITSUBISHI CHEMICAL CORPORATION (JP) 2004-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060106181-A1 Method for producing allyl compound, and ether or ester compound produced thereby AGPAT5, TST, AGPAT2 NR4A1 2867/4885NR4A2 3598/4885NR4A3 3566/4885
US-20040147757-A1 Method for producing allyl compound, and ether or ester compound produced thereby AGPAT5, TST, AGPAT2 NR4A1 2867/4885NR4A2 3598/4885NR4A3 3566/4885
US-20040092777-A1 Method for producing allyl compound CCNT1, APEX1, REV1 NR4A1 3328/4885NR4A2 3995/4885NR4A3 4010/4885
US-20050075518-A1 Method for producing allyl compound, and allyl compound produced thereby CCNT1, AOC3, ATL3 NR4A1 2300/4885NR4A2 3581/4885NR4A3 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.